MacroGenics: 2Q Earnings Snapshot

ROCKVILLE, Md. (AP) _ MacroGenics Inc. (MGNX) on Tuesday reported a loss of $43.2 million in its second quarter.

On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.03.

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.20 per share.

The biopharmaceutical company posted revenue of $18.8 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $4.4 million.

MacroGenics shares have increased 3 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $19.60, an increase of 15 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX